Hitachi Medical Systems America Inc. has received FDA 510(k) clearance for its Scenaria Advanced 128 CT system, the company announced.
Hitachi Medical Systems America Inc. has received FDA 510(k) clearance for its Scenaria Advanced 128 CT system, the company announced.
Scenaria, the newest model of in their scalable CT platform, provides radiation dose saving technology, as well as patient access and workflow features. The Advanced 128 features are also available as a field upgrade for the Scenaria 64-slice model, the company said.
The system meets the need for a CT system that provides routine and advanced applications, the company said.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.